Brii Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan '25 Jan 27, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	104	213	687	3,039	-	-
Market Cap Growth	-67.62%	-69.03%	-77.38%	-	-	-
Enterprise Value	-232	-171	199	3,764	-	-
Last Close Price	0.13	0.23	0.95	-	-	-
PS Ratio	17.88	26.80	38.77	208.62	-	-
PB Ratio	0.24	0.49	1.50	5.83	-	-
P/TBV Ratio	0.26	0.53	1.56	5.79	-	-
EV/Sales Ratio	-	-	11.22	258.41	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	-1.40	-2.56
Asset Turnover	0.01	0.02	0.03	0.04	0.07	-
Quick Ratio	35.26	21.70	13.33	12.13	1.88	14.27
Current Ratio	37.81	22.11	13.43	12.16	1.90	14.31
Return on Equity (ROE)	-9.18%	-5.92%	-15.14%	-534.39%	-	-
Return on Assets (ROA)	-10.12%	-10.32%	-9.17%	-15.64%	-48.59%	-
Return on Capital (ROIC)	-10.45%	-10.89%	-9.88%	-18.98%	-68.10%	-
Earnings Yield	-35.05%	-11.58%	-10.22%	-21.57%	-	-
FCF Yield	-61.63%	-39.35%	-10.47%	-4.56%	-	-
Buyback Yield / Dilution	-0.40%	-0.64%	-64.78%	-129.57%	-7.08%	-
Total Shareholder Return	-0.40%	-0.64%	-64.78%	-129.57%	-7.08%	-

Source: S&P Capital IQ. Standard template. Financial Sources.